Schrodinger Inc. (SDGR) Reports Q1 Revenues Beat; Offers FY21 Revenues Outlook

Go back to Schrodinger Inc. (SDGR) Reports Q1 Revenues Beat; Offers FY21 Revenues Outlook

Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update

May 11, 2021 7:01 AM EDT

First quarter total revenue of $32.1 million, up 23 percent year-over-year; Software revenue of $26.3 million, up 11 percent year-over-year

Expanded agreement with AstraZeneca; New agreement with NVIDIA

Development candidate selected for MALT1 inhibitor program; Internal pipeline progressing with plans to submit up to three investigational new drug applications to the FDA in 2022

Company maintains full-year 2021 financial outlook

NEW YORK--(BUSINESS... More